F A Gesek
Index: Hypertension 33(1 Pt 2) , 524-9, (1999)
Full Text: HTML
Alpha-Adrenergic receptor (AR) activation enhances sodium retention in certain forms of hypertension. The objective of the present study was to understand the role of alpha-ARs in regulating sodium transport by distal tubules (DT). DT cells were isolated from kidneys of spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats at 6 weeks, when hypertension is developing, or at 12 weeks, when hypertension is established. The alpha1-AR agonist phenylephrine increased 22Na uptake by 50% into DT cells of 6-week SHR; no effect was observed with WKY cells. The alpha2-AR agonist B-HT 933 increased uptake by only 10%. At 12 weeks, the pattern of alpha-AR regulation was reversed: alpha1-AR-induced sodium uptake was only 15%, whereas alpha2-AR activation increased sodium uptake by 35% in SHR and WKY cells. alpha1-AR-induced sodium uptake in 6-week SHR cells was abolished by prazosin; alpha2-AR-stimulated sodium uptake was blocked by yohimbine in 12-week SHR and WKY. Competitive binding studies were performed with [3H]prazosin and alpha1A-, alpha1B-, and alpha1D-selective antagonists with DT cell membranes from 6- and 12-week SHR and WKY. alpha2-AR subtypes were determined with [3H]rauwolscine and alpha2A- and alpha2B-selective antagonists. Expression of alpha1B-ARs was increased 4-fold in DT cells during the developing phase of hypertension in SHR. No change was detected in alpha2-AR expression. DT cells transiently increase [Ca2+]i in response to alpha1-AR agonists from 6-week but not 12-week SHR. Conversely, alpha2-AR agonists increase [Ca2+]i at 12 weeks. In summary, during developing hypertension, alpha1-ARs increase sodium uptake and [Ca2+]i in SHR cells. Expression of alpha1B-ARs is selectively upregulated during developing hypertension. In established hypertension (and normotension), alpha2-ARs regulate sodium transport and [Ca2+]i in DT cells. We conclude that a molecular switch of alpha1-AR and alpha2-AR signaling occurs in DT cells during the development of hypertension.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Azepexole dihydrochloride
CAS:36067-72-8 |
C9H17Cl2N3O |
The role of several alpha(1)- and alpha(2)-adrenoceptor subt...
2001-03-01 [Br. J. Pharmacol. 132 , 1292-1298, (2001)] |
Pharmacological evidence that alpha2A- and alpha2C-adrenocep...
2007-01-12 [Eur. J. Pharmacol. 554(2-3) , 205-11, (2007)] |
Evidence that some imidazoline derivatives inhibit periphera...
2008-12-05 [Auton. Neurosci. 143(1-2) , 40-5, (2008)] |
Inhibition of placental 11beta-hydroxysteroid dehydrogenase ...
2001-12-01 [Am. J. Physiol. Regul. Integr. Comp. Physiol. 281(6) , R1966-74, (2001)] |
Characterization of postjunctional alpha-adrenoceptors in th...
1999-07-01 [Gen. Pharmacol. 33(1) , 99-105, (1999)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved